27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Aurora Cannabis Inc (NYSE:ACB) stock plummeted more than 8.7 percent Thursday morning after the company announced plans for a $250 million debt offering.
What Happened?
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
After Wednesday's market close, Aurora announced a $250 million private placement of convertible senior notes due in 2024. The deal would also include the option for the buyers to purchase an additional $37.5 million in notes.
Why It’s Important
Aurora said the money raised from the offering will be used to grow its business, both in Canada and internationally. The company also plans to use the money for strategic acquisitions and working capital requirements.
While most smaller, high-growth companies with international expansion aspirations will need significant amounts of capital to expand, the $250 million offering of convertible debt means major dilution for current shareholders down the line. Aurora’s market cap prior to the announcement was only $7.31 billion.
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
Earlier this week, Aurora announced a $175 million buyout of Whistler Medical Marijuana Corporation. After completion of its second production facility in 2019, Whistler is expected to have a total capacity of 5,000 kilograms per year.
What’s Next
Aurora investors will be watching to see if the fundraising round results in management being more aggressive with the company’s growth efforts. Aurora issued fiscal second-quarter revenue guidance of between $50 million and $55 million earlier this month, well short of consensus analyst expectations of $67 million.
While investors may be disappointed with the dilution associated with the new debt offering, the company could win back some market confidence if the cash infusion helps get its revenue growth trends back on track.
Shares traded around $6.81 at time of publication.
Related Links:
'It's Our Turn Now For Wealth Creation,' iAnthus CEO Tells Cannabis Capital Conference
Multistate Operators Respond To Changing Cannabis Market
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.